A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

NCT03016715 ·Status: UNKNOWN ·Phase: PHASE2

Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa

NCT04727268 ·Status: UNKNOWN

Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro

NCT06177353 ·Status: RECRUITING

Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs

NCT01033552 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

NCT02960997 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

NCT03578029 ·Status: TERMINATED ·Phase: PHASE2

Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene

NCT05529134 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Open-Label Extension Study to Evaluate the Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

NCT02090283 ·Status: TERMINATED ·Phase: PHASE2

Establishment of the National Epidermolysis Bullosa Registry

NCT00004761 ·Status: COMPLETED

A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa

NCT04213261 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa

NCT04217538 ·Status: COMPLETED

A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa

NCT04599881 ·Status: COMPLETED ·Phase: PHASE2

Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa

NCT03158662 ·Status: COMPLETED

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)

NCT05838092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Gentamicin for Junctional Epidermolysis Bullosa

NCT03526159 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Short Term Observational Study in DEB Patients

NCT02178969 ·Status: COMPLETED

Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB

NCT02004600 ·Status: WITHDRAWN ·Phase: NA

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

NCT05157958 ·Status: RECRUITING ·Phase: PHASE2

Study of in Vivo and in Vitro Transcriptomic and Proteomic Signatures in Unhereditary Ichtyosis

NCT05312073 ·Status: COMPLETED ·Phase: NA

Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

NCT03392909 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)

NCT06563414 ·Status: RECRUITING

Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa

NCT02323789 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita

NCT00004359 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

NCT03752905 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa

NCT03529877 ·Status: COMPLETED ·Phase: PHASE1/PHASE2